Projects research

INFO & CONTACTS: +39 02 2390 1

Search

Search

Exploring the potential of liquid biopsies in Wilms tumor patients offers exciting possibilities for enhancing diagnosis, treatment monitoring, and prognosis

Funding Entity: 5x1000

Principal Investigator: Dr. Perotti Daniela - Co Principal Investigator: Dott.ssa Gattuso Giovanna

Start date: 01/01/2025 - End date: 31/12/2027

Main Facility: Predictive Medicine: Molecular Bases of Genetic Risk
Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach (Late-AYA)

Funding Entity: HORIZON-MISS-2024-CANCER-01

Start date: 01/01/2025 - End date: 31/12/2030

Main Facility: Oncologia Medica 1
Extraction of immunotherapy clinical features in Non-Small Cell Lung Cancer using privacy-preserving Large Language Models

Funding Entity: Bando per la Ricerca Istituzionale

Principal Investigator: Dr. Mazzeo Laura - Co Principal Investigator: Dott.ssa Corso Federica

Start date: 01/01/2025 - End date: 31/12/2027

Main Facility:
Joint Action on Networks of Expertise on Cancer - JANE-2

Funding Entity: European Health and Digital Executive Agency (HADEA)

Principal Investigator: Prof. Casali Paolo G. - Co Principal Investigator: Dr. Trama Annalisa

Start date: 01/11/2024 - End date: 31/10/2028

Main Facility: Oncologia Medica 2
Analysis of drug consumption: 2019-2022 population study

Principal Investigator: Dr. Giovanna Tagliabue

Start date: 25/09/2024 - End date: 31/03/2025

Main Facility: Cancer registries
Matching primary tumor and blood gene expression analysis of HPV-negative squamous head and neck cancers (BIOMATCH - Head and Neck) - PNRR-MCNT1-2023-12377359

Funding Entity: Ministero della Salute (Bando PNRR 2023)

Principal Investigator: Associate Professor Licitra Lisa Francesca Linda - Co Principal Investigator: Dr, PhD De Cecco Loris

Start date: 31/08/2024 - End date: 30/08/2026

Main Facility: Oncologia Medica 3 - Tumori testa-collo
Optimizing biomarkers of immunotherapy response in clinical studies summarizing head and neck cancer natural history

Funding Entity: AIRC

Principal Investigator: Associate Professor Licitra Lisa Francesca Linda - Co Principal Investigator: Dr, PhD De Cecco Loris

Start date: 31/08/2024 - End date: 31/08/2026

Main Facility: Oncologia Medica 3 - Tumori testa-collo
IMPATHY-AML: Integrating Molecular and digital PATHologY to track new response biomarkers in high-risk Acute Myeloid Leukemia

Funding Entity: Ministero della Salute (Bando PNRR 2023)

Start date: 31/08/2024 - End date: 31/08/2026

Main Facility: Molecular Immunology
A national multicenter pediatric framework and digital infrastructure to foster the genomic approach for children and adolescents with highrisk solid tumors

Funding Entity: Ministero della Salute (Bando PNRR 2023)

Start date: 31/08/2024 - End date: 31/08/2026

Main Facility: Pediatric (Oncology)
Artificial intelligence and compUtational biology for pRedicting nOvel immunotheRApeutic strategies in microsatellite stability colon cancer patients - AURORA

Funding Entity: Ministero della Salute (Bando PNRR 2023)

Start date: 31/08/2024 - End date: 30/08/2026

Main Facility: Molecular Diagnostics and Research
A composite assay for HER2-positive early-stage breast cancer management

Funding Entity: Ministero della Salute (Bando PNRR 2023)

Principal Investigator: Dr. Verderio Paolo - Co Principal Investigator: PhD Di Cosimo Serena

Start date: 31/08/2024 - End date: 30/08/2026

Main Facility: Bioinformatics and Biostatistics Unit
B7-H3 COME POTENZIALE BERSAGLIO PER L'IMMUNOTERAPIA BASATA SUI CAR CONTRO I SARCOMI PEDIATRICI DELL’OSSO E DEI TESSUTI MOLLI

Funding Entity: Fondazione Bianca Garavaglia e Fondazione IRCCS Istituto Nazionale dei Tumori di Milano

Principal Investigator: PhD Gasparini Patrizia - Co Principal Investigator: Prof. Ferrari Andrea

Start date: 01/07/2024 - End date: 31/07/2026

Main Facility: Epigenomics and Biomarkers of Solid Tumors
Shifting Pediatric Brain Tumor Diagnostics from Solid Tissue to Liquid-biopsies Approaches SOLID-2-LIQUID

Funding Entity: Associazione Bianca Garavaglia

Principal Investigator: Dott.ssa Biassoni Veronica - Co Principal Investigator: Dr, PhD De Cecco Loris

Start date: 01/07/2024 - End date: 31/12/2026

Main Facility: Pediatric (Oncology)
EUCanScreen: a European project to improve cancer screening

Funding Entity: Commissione Europea

Start date: 01/06/2024 - End date: 31/05/2028

Main Facility: Scientific Directorate
DISSECTING THE ROLE OF INNERVATION IN THYROID CANCER

Funding Entity: Fondi 5Xmille istituzionali

Start date: 03/03/2024 - End date: 31/08/2025

Main Facility: Integrated Biology of Rare Tumors
BuonMarrow: Bone Marrow-on-Chip as smart sensor of lung cancer relapse

Funding Entity: programma Horizon Europe

Principal Investigator: PhD Sangaletti Sabina - Co Principal Investigator: Dr. Prelaj Arsela

Start date: 01/03/2024 - End date: 28/02/2027

Main Facility: Molecular Immunology
Trapping circulating tumor cells to develop prognostic biomarkers and novel anti-metastatic strategies in lung cancer “Trap4Cure”

Funding Entity: Fondazione IRCCS Istituto Nazionale dei Tumori

Principal Investigator: PhD Bertolini Giulia - Co Principal Investigator: Dr. Lo Russo Giuseppe

Start date: 01/02/2024 - End date: 31/01/2027

Main Facility: Epigenomics and Biomarkers of Solid Tumors
A prospective web-based cohort and biobank of women carriers of BRCA mutations (e-BRAVE study)

Funding Entity: Bando Linee di ricerca istituzionali 2024

Principal Investigator: Dr. Pasanisi Patrizia

Start date: 01/02/2024 - End date: 31/01/2027

Main Facility: Research in Nutrition and Metabolomics
Exploiting Artificial Intelligence-based tools for analysis of clinical breathomics data

Funding Entity: Fondazione IRCCS Istituto Tumori di Milano

Principal Investigator: Dr. Orlandi Rosaria

Start date: 01/02/2024 - End date: 31/01/2026

Main Facility: Research in Nutrition and Metabolomics
Gene expression profiling in advanced thymic epithelial tumors (TETs) and integration with clinical outcomes in a real-world setting

Funding Entity: Linea di Ricerca 3 – Traiettoria A _INT 2023

Principal Investigator: Dr. Ganzinelli Monica

Start date: 01/02/2024 - End date: 31/01/2027

Main Facility:

Projects research

Subscribe to the newsletter